Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas
Massachusetts General Hospital
Massachusetts General Hospital
University of Washington
University of Rochester
Celgene
Shanghai Junshi Bioscience Co., Ltd.
Wake Forest University Health Sciences
Roswell Park Cancer Institute
University of Chicago
CARGO Therapeutics
Miltenyi Biomedicine GmbH
Gilead Sciences
M.D. Anderson Cancer Center
Peking University Cancer Hospital & Institute
Sunnybrook Health Sciences Centre
Masonic Cancer Center, University of Minnesota
The First Affiliated Hospital of Soochow University
National Institutes of Health Clinical Center (CC)
Seagen Inc.
National Heart, Lung, and Blood Institute (NHLBI)
Oncology Specialists, S.C.
Seagen Inc.
Stanford University
Genentech, Inc.
Duke University
Fondazione Italiana Linfomi - ETS
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Heidelberg University